Unit 3 Micro: Glaxo SmithKline fined $3 billion for off-label marketing
The scale of the fine is staggering, Glaxo SmithKline has been found guilty of off-label marketing - an illegal strategy - GSK targeted the antidepressant Paxil at patients under age 18 when it was approved only for adults, and promoted the drug Wellbutrin for uses it was not approved for, including weight loss and treatment of sexual dysfunction
This is corporate irresponsibility on a grand scale as this new report makes clear.
This course focuses solely on teaching & learning resources and approaches to delivering the wider range of quantitative methods contained in the new A Level and AS Level specifications. We've put together a comprehensive collection of teaching materials that will help accelerate your planning and preparation for the extended QM elements for A Level Economics.